Finding into death of Anna Lawrence
Deceased
Anna Lawrence
Demographics
64y, female
Date of death
2020-04-30
Finding date
2023-02-22
Cause of death
Combined toxicity to alcohol and baclofen
AI-generated summary
Anna Lawrence, 64, died from combined toxicity of alcohol and baclofen on 30 April 2020. She had a 40+ year history of alcohol dependency, borderline personality disorder, depression, and multiple suicide attempts. Baclofen was prescribed off-label for alcohol craving management by her psychiatrist in January 2019 but not redeemed until August 2019—approximately 1.5 years before her death. The coroner found no evidence that any clinician's conduct contributed to her death. However, the finding highlights systemic issues: baclofen lacks TGA approval for alcohol use disorder despite widespread off-label prescribing in Australia, creating an unregulated prescribing environment dependent on individual clinician judgment. The coroner recommends TGA consider approving baclofen for alcohol use disorder to establish safer prescribing guidelines, controlled dispensing protocols, and clearer contraindications for high-risk patients with mental illness or suicide history.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Error types
Drugs involved
Contributing factors
- Long-term mental ill-health and borderline personality disorder
- Chronic alcohol use disorder
- Complex personal relationship issues including marital breakdown
- Divorce settlement stress and financial disputes
- Estrangement from family and sons
- Off-label prescribing of baclofen without TGA approval for alcohol use disorder
- Possible stockpiling of baclofen medication
- History of multiple suicide attempts
- Social isolation and loss of motivation
Coroner's recommendations
- The Therapeutic Goods Administration should consider revising the Australian Register of Therapeutic Goods entry for baclofen to include alcohol use disorder as an approved indication in order to achieve safer prescribing practices, establish clear clinical guidelines, and reduce the risk of death by baclofen overdose
Full text
Related cases
Source and disclaimer
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —